39757-34-1

Basic information

• Product Name: METHYL 4-(4-FLUOROPHENYL)-2,4-DIOXOBUTANOATE
• Synonyms: F80114;Methyl 4-fluoro-a,g-dioxo-benzenebutanoate;Methyl 4-(4-fluorophenyl)-2,4-dioxobutanoate≥ 98% (HPLC);methyl 4-(4-fluorophenyl)-2,4-diketobutyrate
• CAS NO: 39757-34-1
• Molecular Formula: C₁₁H₉FO₄
• Molecular Weight: 0
• Mol File: 39757-34-1.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 348.7°C at 760 mmHg
• Flash Point: 159.2°C
• Appearance: /
• Density: 1.278g/cm³
• Vapor Pressure: 4.94E-05mmHg at 25°C
• Refractive Index: 1.504
• CAS DataBase Reference: METHYL 4-(4-FLUOROPHENYL)-2,4-DIOXOBUTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-(4-FLUOROPHENYL)-2,4-DIOXOBUTANOATE(39757-34-1)
• EPA Substance Registry System: METHYL 4-(4-FLUOROPHENYL)-2,4-DIOXOBUTANOATE(39757-34-1)

Safety Data

• Hazardous Substances Data: 39757-34-1(Hazardous Substances Data)

Usage

Chemical Properties

Pale yellow powder

InChI:InChI=1/C11H9FO4/c1-16-11(15)10(14)6-9(13)7-2-4-8(12)5-3-7/h2-5H,6H2,1H3

Upstream product

• 553-90-2 Dimethyl oxalate 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 95-92-1 oxalic acid diethyl ester 

Downstream Products

• 66156-01-2 3-Chloro-4-(4-fluoro-phenyl)-2,4-dioxo-butyric acid methyl ester 
• 170570-80-6 methyl 5-(4-fluorophenyl)-1-(4-sulfamoylphenyl)-1H-pyrazole-3-carboxylate 
• 887250-27-3 3-(4-fluorobenzoyl)-5-phenyl-1,2,4,5-tetrahydropyrrolo[1,2-a]quinoxaline-1,2,4-trione 
• 170571-29-6 1-[4-(aminosulfonyl)phenyl]-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide 
• 170570-81-7 5-(4-fluorophenyl)-1-(4-sulfamoylphenyl)-1H-pyrazole-3-carboxylic acid 
• 1186021-64-6 3-[2-(4-fluorophenyl)-2-oxoethyl]-2H-[1,2,4]triazino-[2,3-c]quinazolin-2-one 
• 1186021-71-5 3'-(2-aminophenyl)-3-(4-fluorophenyl)-spiro[pyrazoline-5,6'(1'H)-1,2,4-triazin]-5'(4'H)-one 
• 1289383-33-0 (Z)-3-[2-oxo-2-(4-fluorophenyl)ethylidene]-3,4-dihydroquinoxalin-2(1H)-one 
• 1289383-56-7 3-(4-fluorobenzoyl)furo[3,2-b]quinoxalin-2(4H)-one 
• 192701-91-0 methyl 5-(4-fluorophenyl)-1H-pyrazole-3-carboxylate 
• 890006-82-3 5-(4-fluoro-phenyl)-1H-pyrazole-3-carboxylic acid 
• 1437792-15-8 N-(6-chlorobenzo[d]thiazol-2-yl)-7-(4-fluorophenyl)-2-phenylpyrazolo[1,5-a]pyrimidine-5-carboxamide 
• 1437792-24-9 N-(6-methoxybenzo[d]thiazol-2-yl)-7-(4-methoxyphenyl)-2-phenylpyrazolo[1,5-a]pyrimidine-5-carboxamide 
• 1437792-27-2 N-(6-methoxybenzo[d]thiazol-2-yl)-2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide 

Relevant articles and documents

Design, synthesis, biological evaluation and in silico studies of pyrazole‐based nh2‐acyl oseltamivir analogues as potent neuraminidase inhibitors

Oseltamivir represents one of the most successful neuraminidase (NA) inhibitors in the current anti‐influenza therapy. The 150‐cavity of NA was identified as an additional binding pocket, and novel NA inhibitors have been designed to occupy the 150‐cavity

Non-peptide-based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies

A series of 2-oxo-2-phenylethylidene linked 2-oxo-benzo[1,4]oxazine analogues 17a–x and 18a–o, incorporated with a variety of electron-withdrawing as well as electron-donating groups at ring A and ring C, were synthesized under greener conditions in excel

CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME

The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.